enVVeno Medical (NVNO) Current Deferred Revenue (2017 - 2021)

enVVeno Medical's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $33000.0 for Q3 2021.

• In Q3 2021, Current Deferred Revenue changed 0.0% year-over-year to $33000.0; the TTM figure through Sep 2021 stood at $33000.0 (changed 0.0% YoY), while the FY2020 annual figure was $33000.0, changed 0.0% from the prior year.
• Current Deferred Revenue was $33000.0 for Q3 2021 at enVVeno Medical, roughly flat from $33000.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $103400.0 in Q4 2017 to a low of $33000.0 in Q4 2018.
• Historically, Current Deferred Revenue has averaged $39342.9 across 5 years, with a median of $33000.0 in 2018.
• The sharpest annual moves came in 2018 and 2019: Current Deferred Revenue plunged 68.09% in 2018, then changed 0.0% in 2019.
• A 5-year view of Current Deferred Revenue shows it stood at $103400.0 in 2017, then slumped by 68.09% to $33000.0 in 2018, then changed by 0.0% to $33000.0 in 2019, then changed by 0.0% to $33000.0 in 2020, then changed by 0.0% to $33000.0 in 2021.
• The last three Current Deferred Revenue figures came in at $33000.0 (Q3 2021), $33000.0 (Q2 2021), and $33000.0 (Q4 2020), per Business Quant data.